Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. Coronavirus (COVID-19) Message Board

Feds Call for halt in J&J vaccine rollout. http

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 716
(Total Views: 708)
Posted On: 04/13/2021 9:54:06 AM
Avatar
Posted By: someconcerns
Feds Call for halt in J&J vaccine rollout.

https://www.fiercepharma.com/pharma/feds-call...kid=944797

Quote:
After drug regulators on both sides of the Atlantic revealed safety probes into Johnson & Johnson’s COVID-19 vaccine, U.S. officials are calling for an immediate pause to the rollout.

Since the vaccine’s late February emergency use authorization in the U.S., nearly 7 million people have received the shot. Six recipients of the vaccine—all women between 18 and 48—were diagnosed with rare blood clots afterward, the FDA says. One died and one has been hospitalized, The New York Times reports.

The FDA on Tuesday said it’s “recommending a pause in the use of this vaccine out of an abundance of caution.”

The pause represents a big setback for the J&J vaccine itself and the U.S. vaccination effort generally. AstraZeneca's vaccine—which, like J&J's, is adenovirus-based—has also raised rare blood clot concerns, and that has led to a sporadic vaccination effort in Europe, where individual countries are setting vaccine policy.

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices—which reviews data and makes vaccination recommendations for the U.S.—will meet Wednesday to discuss the data. The FDA is investigating the rare clotting cases and will review the committee’s analysis.

A J&J spokeswoman last week said the company is working with regulators as more data come in and supports the "open communication" of any new findings with healthcare providers so they can monitor for risks.

"Our close tracking of side effects has revealed a small number of very rare events following vaccination," she said. "At present, no clear causal relationship has been established between these rare events and the Janssen COVID-19 vaccine."

The news comes after the FDA and European Medicines Agency (EMA) late last week acknowledged they were investigating the vaccine after cases of rare blood clots. EMA officials said they were investigating three cases of unusual blood clots with low blood platelets following vaccination with J&J’s shot. Another case came in a clinical trial. One of the cases was fatal.

The FDA disclosed its own probe hours later, saying it had not "found a causal relationship with vaccination."

So far, 190 million COVID-19 vaccine doses have been administered in the U.S

.


(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us